Tag: prescription drugs

Computer with brain images and a blood sample

The drug companies want $26,500 per year for the newest Alzheimer’s drug; negotiations might take it to $20,000.  The potential for full Food and Drug Administration approval of the new Biogen-Esai Alzheimer’s drug (Leqembi) means that Medicare may make the drug available to beneficiaries.  The $26,500 annual price tag associated with Leqembi will wreak havoc wit…

NCOA Benefits Checkup

Fewer than half of low-income retirees who are eligible for SNAP food stamps or don’t automatically receive a medication subsidy as part of their Medicaid coverage are taking advantage of the programs. These are two prominent examples of the head-spinning number of assistance programs for people over 60, from state property tax breaks and veterans…